IBA Proton Therapy

IBA Proton Therapy IBA, Proton Therapy Unlimited! Want to get an insider view on how proton therapy develops worldwide?Go behind the scene with us.

The information shared on this Social Media channel is intended solely for the use of healthcare professionals.

Excited to be at ASTRO 2025 in San Francisco!Come visit us at booth  #2013 to discover our latest innovations and enjoy ...
29/09/2025

Excited to be at ASTRO 2025 in San Francisco!
Come visit us at booth #2013 to discover our latest innovations and enjoy a warm cup of coffee ☕.

📢 Don’t miss the insightful talk by Steven Frank on 𝗠𝗼𝗻𝗱𝗮𝘆 𝗮𝘁 𝟭𝟬:𝟭𝟱 𝗔𝗠, right at our booth for a talk about 𝗽𝗿𝗼𝘁𝗼𝗻 𝘁𝗵𝗲𝗿𝗮𝗽𝘆 𝗳𝗼𝗿 𝗵𝗲𝗮𝗱 𝗮𝗻𝗱 𝗻𝗲𝗰𝗸 𝗰𝗮𝗻𝗰𝗲𝗿.
Together, 𝗹𝗲𝘁’𝘀 𝗯𝗿𝗶𝗱𝗴𝗲 𝘁𝗵𝗲 𝗽𝗿𝗼𝘁𝗼𝗻 𝘁𝗵𝗲𝗿𝗮𝗽𝘆 𝗴𝗮𝗽 and advance cancer care through collaboration and innovation.

Varian, a Siemens Healthineers company, and IBA Proton Therapy have entered into a Memorandum of Understanding to evalua...
29/09/2025

Varian, a Siemens Healthineers company, and IBA Proton Therapy have entered into a Memorandum of Understanding to evaluate areas for strategic collaboration with the aim to strengthen interoperability and enhance clinical workflows in proton therapy, supporting our shared mission of improving access to care.

🌀 Eclipse and Proteus®ONE Compatibility – Varian’s Eclipse treatment planning system is now seamlessly compatible with IBA’s Proteus®ONE platform, enabling clinicians to streamline planning and delivery with optimized workflows.

🖼️ Launching DynamicARC® Planning in Eclipse – Both Varian and IBA are evaluating future possibilities for arc-based proton therapy planning in Eclipse. This collaboration aims to explore opportunities in treatment personalization and delivery efficiency, while continuing to advance current innovations across our platforms.

⚡Next-Generation Imaging in Proton Therapy – Together, IBA and Varian will explore co-developing advanced imaging solutions to enhance accuracy and confidence in patient positioning.

🧠 FLASH Therapy Quality Assurance – Joint efforts are underway to explore opportunities in quality assurance practices that may help enable future clinical implementation of FLASH therapy.

This developing collaboration underscores a shared commitment to expanding access, strengthening clinical workflows, and advancing intelligent cancer care. 🤝 Learn more at

* Flash therapy is under development and not available for sale. The products/features mentioned here are not commercially available in all countries. Their future availability cannot be guaranteed.
QR700029693

We are proud to announce that we have signed a 𝗰𝗼𝗻𝘁𝗿𝗮𝗰𝘁 to install a 𝗣𝗿𝗼𝘁𝗲𝘂𝘀®𝗢𝗡𝗘 compact proton therapy solution to be l...
20/08/2025

We are proud to announce that we have signed a 𝗰𝗼𝗻𝘁𝗿𝗮𝗰𝘁 to install a 𝗣𝗿𝗼𝘁𝗲𝘂𝘀®𝗢𝗡𝗘 compact proton therapy solution to be located on the University campus in 𝗛𝗲𝗶𝗱𝗲𝗹𝗯𝗲𝗿𝗴, 𝗚𝗲𝗿𝗺𝗮𝗻𝘆.
The acquisition of this ProteusONE system marks a strategic expansion of Universitätsklinikum Heidelberg (UKHD)'s particle therapy program, which has been treating patients since 2010, ensuring continued access to cutting-edge, highly targeted treatment for patients with cancer using the latest techniques in proton therapy. This investment further strengthens UKHD’s role as a global reference center for precision radiation oncology, combining scientific excellence with patient-centered innovation.

👉 Read the full press release here: https://www.iba-worldwide.com/heidelberg-university-hospital-expands-its-particle-therapy-program-ibas-proteusrone-solution

15/07/2025

Have you heard of proton therapy, but are not quite sure how it works?

Our short and simple video explains everything!

Watch it here and share with someone who might find it helpful 👇

08/07/2025

💡 How does Proton Therapy work? Our newest video simplifies the science behind one of the most precise cancer treatments available today.[1]

In less than 3 minutes, understand how proton therapy targets tumors while sparing healthy tissue.[2]



[1] Baumann BC, et al. Comparative Effectiveness of Proton vs Photon Therapy as Part of Concurrent Chemoradiotherapy for Locally Advanced Cancer. JAMA Oncol. 2020;6(2):237-246.

[2] Mohan R. A Review of Proton Therapy - Current Status and Future Directions. Precis Radiat Oncol. 2022 Jun;6(2):164-176.

08/05/2025

🚀 The Strong Partnership Between Proton Therapy Providers and Clinical Centers


As Dr. Anthony Zietman from Massachusetts General Hospital explains, the collaboration between a proton therapy provider and a clinical center is built on trust and mutual commitment, and it plays a pivotal role in advancing patient care.

In this insightful discussion, Dr. Zietman emphasizes the importance of selecting the right proton therapy partner—one that not only meets today's needs but also supports future advancements in radiation oncology. 🌱

Choosing the right partner isn’t just a decision for today; it’s a choice for tomorrow’s breakthroughs in proton therapy.

Let’s continue to advance patient care with the right collaborations. 🔗



🔗 Learn More 👇

In honor of 🌟Head & Neck Cancer Awareness Month🌟, we want to highlight again the groundbreaking research of Dr. Steven F...
18/04/2025

In honor of 🌟Head & Neck Cancer Awareness Month🌟, we want to highlight again the groundbreaking research of Dr. Steven Frank from MD Anderson Cancer Center. His work provides Level 1 evidence that 𝐩𝐫𝐨𝐭𝐨𝐧 𝐭𝐡𝐞𝐫𝐚𝐩𝐲 𝐟𝐨𝐫 𝐨𝐫𝐨𝐩𝐡𝐚𝐫𝐲𝐧𝐠𝐞𝐚𝐥 𝐜𝐚𝐧𝐜𝐞𝐫 𝐚𝐜𝐡𝐢𝐞𝐯𝐞𝐬 𝐬𝐢𝐦𝐢𝐥𝐚𝐫 𝐜𝐥𝐢𝐧𝐢𝐜𝐚𝐥 𝐨𝐮𝐭𝐜𝐨𝐦𝐞𝐬 𝐰𝐡𝐢𝐥𝐞 𝐬𝐢𝐠𝐧𝐢𝐟𝐢𝐜𝐚𝐧𝐭𝐥𝐲 𝐫𝐞𝐝𝐮𝐜𝐢𝐧𝐠 𝐬𝐢𝐝𝐞 𝐞𝐟𝐟𝐞𝐜𝐭𝐬 compared to photon-based radiotherapy.

This research is a game-changer in the field, offering hope and improved quality of life for patients. Let's continue to support and share these advancements in cancer treatment! 💪

📚 Read more on Campus 👉 https://www.campus-iba.com/publications/phase-iii-randomized-trial-intensity-modulated-proton-therapy-impt-versus-intensity

Celebrating 25+ Years of Innovation and Collaboration with MGH! 🌟 We are thrilled to continue our long-standing partners...
15/04/2025

Celebrating 25+ Years of Innovation and Collaboration with MGH! 🌟

We are thrilled to continue our long-standing partnership with Massachusetts General Hospital (MGH), the original and largest teaching hospital of Harvard Medical School ! Over the past 25 years, we have worked hand-in-hand to push the boundaries of medical care, and now, we are celebrating a major milestone.

Together, we are in the process of completing the full refurbishment of the first-ever proton therapy system at MGH! 💡 This is a groundbreaking achievement that not only honors our history but also sets the stage for an exciting future in sustainable proton therapy (PT).

We are excited about the new possibilities we are embracing in the field of radiation oncology, and we are committed to delivering best-in-class patient care through innovative technologies.

Here’s to more milestones, more progress, and more lives improved! 🙌🏼✨

🔗 Learn More 👇🏼
https://www.youtube.com/watch?v=f_Mx26fngn4

Dr. Helen Shih and Dr. Anthony Zietman from Massachusetts General Hospital (MGH) discuss their roles and the advancements in proton therapy. Dr. Shih is the ...

🎉We are proud to announce our 𝘁𝗵𝗶𝗿𝗱 𝗽𝗿𝗼𝘁𝗼𝗻 𝘁𝗵𝗲𝗿𝗮𝗽𝘆 𝘀𝘆𝘀𝘁𝗲𝗺 𝗼𝗿𝗱𝗲𝗿 𝗶𝗻 𝗧𝗮𝗶𝘄𝗮𝗻, this time for 𝗧𝗿𝗶-𝗦𝗲𝗿𝘃𝗶𝗰𝗲 𝗚𝗲𝗻𝗲𝗿𝗮𝗹 𝗛𝗼𝘀𝗽𝗶𝘁𝗮𝗹 in...
02/04/2025

🎉We are proud to announce our 𝘁𝗵𝗶𝗿𝗱 𝗽𝗿𝗼𝘁𝗼𝗻 𝘁𝗵𝗲𝗿𝗮𝗽𝘆 𝘀𝘆𝘀𝘁𝗲𝗺 𝗼𝗿𝗱𝗲𝗿 𝗶𝗻 𝗧𝗮𝗶𝘄𝗮𝗻, this time for 𝗧𝗿𝗶-𝗦𝗲𝗿𝘃𝗶𝗰𝗲 𝗚𝗲𝗻𝗲𝗿𝗮𝗹 𝗛𝗼𝘀𝗽𝗶𝘁𝗮𝗹 in 𝗧𝗮𝗶𝗽𝗲𝗶.🎉
With its cutting-edge technology and future-ready 𝗗𝘆𝗻𝗮𝗺𝗶𝗰𝗔𝗥𝗖® capabilities, our compact 𝗣𝗿𝗼𝘁𝗲𝘂𝘀®𝗢𝗡𝗘 will support the hospital in delivering state-of-the-art cancer treatment. Patient treatments are expected to begin in late 2028.
Thrilled to continue expanding access to proton therapy worldwide!
👉Read the full press release here: https://www.iba-worldwide.com/iba-signs-contract-proteusrone-solution-be-installed-tri-service-general-hospital-taiwan

𝘋𝘺𝘯𝘢𝘮𝘪𝘤𝘈𝘙𝘊 𝘪𝘴 𝘵𝘩𝘦 𝘳𝘦𝘨𝘪𝘴𝘵𝘦𝘳𝘦𝘥 𝘣𝘳𝘢𝘯𝘥 𝘰𝘧 𝘐𝘉𝘈’𝘴 𝘗𝘳𝘰𝘵𝘰𝘯 𝘈𝘳𝘤 𝘵𝘩𝘦𝘳𝘢𝘱𝘺 𝘴𝘰𝘭𝘶𝘵𝘪𝘰𝘯 𝘸𝘩𝘪𝘤𝘩 𝘪𝘴 𝘤𝘶𝘳𝘳𝘦𝘯𝘵𝘭𝘺 𝘶𝘯𝘥𝘦𝘳 𝘳𝘦𝘴𝘦𝘢𝘳𝘤𝘩 𝘢𝘯𝘥 𝘥𝘦𝘷𝘦𝘭𝘰𝘱𝘮𝘦𝘯𝘵. 𝘋𝘺𝘯𝘢𝘮𝘪𝘤𝘈𝘙𝘊 𝘸𝘪𝘭𝘭 𝘣𝘦 𝘢𝘷𝘢𝘪𝘭𝘢𝘣𝘭𝘦 𝘧𝘰𝘳 𝘴𝘢𝘭𝘦 𝘸𝘩𝘦𝘯 𝘳𝘦𝘨𝘶𝘭𝘢𝘵𝘰𝘳𝘺 𝘤𝘭𝘦𝘢𝘳𝘢𝘯𝘤𝘦 𝘪𝘴 𝘳𝘦𝘤𝘦𝘪𝘷𝘦𝘥. 𝘋𝘶𝘦 𝘵𝘰 𝘢 𝘤𝘰𝘯𝘵𝘪𝘯𝘶𝘰𝘶𝘴 𝘳𝘦𝘴𝘦𝘢𝘳𝘤𝘩 𝘢𝘯𝘥 𝘥𝘦𝘷𝘦𝘭𝘰𝘱𝘮𝘦𝘯𝘵 𝘱𝘳𝘰𝘨𝘳𝘢𝘮, 𝘐𝘉𝘈 𝘳𝘦𝘴𝘦𝘳𝘷𝘦𝘴 𝘵𝘩𝘦 𝘳𝘪𝘨𝘩𝘵 𝘵𝘰 𝘮𝘢𝘬𝘦 𝘤𝘩𝘢𝘯𝘨𝘦𝘴 𝘪𝘯 𝘥𝘦𝘴𝘪𝘨𝘯, 𝘵𝘦𝘤𝘩𝘯𝘪𝘤𝘢𝘭 𝘥𝘦𝘴𝘤𝘳𝘪𝘱𝘵𝘪𝘰𝘯𝘴, 𝘢𝘯𝘥 𝘴𝘱𝘦𝘤𝘪𝘧𝘪𝘤𝘢𝘵𝘪𝘰𝘯𝘴 𝘰𝘧 𝘪𝘵𝘴 𝘱𝘳𝘰𝘥𝘶𝘤𝘵𝘴 𝘸𝘪𝘵𝘩𝘰𝘶𝘵 𝘱𝘳𝘪𝘰𝘳 𝘯𝘰𝘵𝘪𝘤𝘦. 𝘚𝘰𝘮𝘦 𝘧𝘦𝘢𝘵𝘶𝘳𝘦𝘴 𝘢𝘳𝘦 𝘶𝘯𝘥𝘦𝘳 𝘥𝘦𝘷𝘦𝘭𝘰𝘱𝘮𝘦𝘯𝘵 𝘢𝘯𝘥 𝘮𝘢𝘺 𝘣𝘦 𝘴𝘶𝘣𝘫𝘦𝘤𝘵 𝘵𝘰 𝘳𝘦𝘷𝘪𝘦𝘸 𝘣𝘺 𝘤𝘰𝘮𝘱𝘦𝘵𝘦𝘯𝘵 𝘢𝘶𝘵𝘩𝘰𝘳𝘪𝘵𝘪𝘦𝘴.

📊 IBA reports solid full year 2024 results. 👉Read the full press release: https://www.iba-worldwide.com/iba-reports-soli...
20/03/2025

📊 IBA reports solid full year 2024 results. 👉Read the full press release: https://www.iba-worldwide.com/iba-reports-solid-full-year-2024-results

📢 Press release

IBA today reports solid results for the 2024 financial year.

Olivier Legrain, Chief Executive Officer of IBA, commented: "We are pleased to report improved topline growth and a return to profitability in 2024. IBA successfully delivered its objective of accelerating backlog conversion across all business units, particularly in the Other Accelerators business."

🔗 Read the full press release here: https://www.iba-worldwide.com/iba-reports-solid-full-year-2024-results

Let's celebrate this significant milestone of the first patient treated using a Monaco proton plan! Congratulations to o...
11/03/2025

Let's celebrate this significant milestone of the first patient treated using a Monaco proton plan! Congratulations to our partners Elekta and the Corewell Health William Beaumont University Hospital Proton Therapy Center.
Read how treatment results showed better dose distribution and critical organ sparing 👉 https://www.elekta.com/focus/michigan-proton-therapy-center-marks-first-patient-treatment-using-a-monaco-proton-plan/

The first patient treated using a Monaco proton plan has successfully completed proton beam therapy at the Corewell Health William Beaumont University Hospital Proton Therapy Center. In FOCUS, read how treatment results showed better dose distribution and critical organ sparing ➡️ https://bit.ly/4byAZ8t

ProteusONE's high-quality beam has a native small spot size, with constant symmetry regardless of gantry angle, helping ...
26/02/2025

ProteusONE's high-quality beam has a native small spot size, with constant symmetry regardless of gantry angle, helping to optimize treatment plans and quality.
Learn why having the sharpest proton beam matters for your patients
➡️https://www.iba-protontherapy.com/magazine/role-proton-beam-quality-cancer-treatment?mtm_campaign=pone%20revamp%20consideration&mtm_kwd=social%2015&mtm_source=Facebook&mtm_medium=organic&mtm_content=The%20role%20of%20proton%20beam%20quality%E2%80%8B&mtm_group=pone%20revamp

Adres

Chemin Du Cyclotron 3
Louvain-la-Neuve
1348

Meldingen

Wees de eerste die het weet en laat ons u een e-mail sturen wanneer IBA Proton Therapy nieuws en promoties plaatst. Uw e-mailadres wordt niet voor andere doeleinden gebruikt en u kunt zich op elk gewenst moment afmelden.

Contact De Praktijk

Stuur een bericht naar IBA Proton Therapy:

Delen

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram